
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
Follow the latest financial and economic news, market updates, reports, and analysis on PipVero.

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.

The software company also came up short on expectations for revenue in the latest quarter.

DT beats fiscal Q1 estimates as ARR rose 17%, net new ARR jumps 66%, and larger new-logo deals fuel subscription-led growth.

Duolingo beat Q2 estimates as revenues, daily users and paid subscribers grow, while lower AI costs support a higher profitability outlook.

Zeta Global's Q2 revenues jump 43.5% as AI adoption, customer growth, and platform usage fuel results and a stronger outlook for 2026.

DASH's Q2 revenues beat estimates as order growth and Deliveroo lift sales, but surging R&D costs weigh on earnings.

Datadog Inc (NASDAQ:DDOG) shares tumbled more than 18% on Thursday even after the software company delivered what analysts called a high-quality quarter, as investors focused on decelerating bookings growth and softer-than-expected third-quarter guidance. Datadog's revenue grew 35.6% year-over-year in the second quarter, ahead of the company's 29-31% guidance range and accelerating from 32% growth in the first quarter.

Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (TARS) Q2 2026 Earnings Call Transcript

The Real Brokerage Inc. (REAX) Q2 2026 Earnings Call Transcript

$12.1 billion. That was Chevron's reported net income in its latest quarter, far above the $2.5 billion it reported in the same period last year.

Summit Hotel Properties, Inc. (INN) Q2 2026 Earnings Call Transcript

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Bloom Energy Corporation ("Bloom Energy" or the "Company") (NYSE: BE) on behalf of investors that purchased or otherwise acquired Bloom Energy securities between February 27, 2025 and July 8, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Bloom Energy and have suffered losses, you may CLICK HERE to contact us.

Two facts about the Schwab U.S. Large-Cap Growth ETF (NYSEARCA:SCHG) tell you almost everything you need to decide whether it belongs in your portfolio.

IRVINE, Calif., Aug. 6, 2026 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces the Company has arranged a $718.5 million Single-Asset, Single-Borrower (SASB) recapitalization for a 13-property multifamily portfolio comprising 3,321 units across Arizona, Nevada and Utah on behalf of owner Keller Investment Properties.